3,719 followers
🚨POR Editors' Pick of the Month!🚨 Researchers from @semmelweishu discuss the long-term outcomes of refractory/relapsed hairy cell leukaemia patients treated with low-dose vemurafenib between 2013 and 2022. Read and download the full article ⬇ https://t.c